Aspire BioPharma is trading 12.4% up at $7.33 amid a broad market rally and improving risk appetite.
- The move appears aligned with major U.S. indexes, which are all trading more than 1% higher today.
- There are no fresh company-specific announcements or earnings reports driving the price action.
- The stock is benefiting from a general shift toward cyclical and growth names as investor sentiment improves.